Nasal spray peptides on TikTok: hype vs. what we know

What did @ninageezzy actually say?

In a short TikTok, @ninageezzy rattled off five nasal spray peptides with single-line descriptions: D-SIP for "deep sleep and stress relief," C-Max for "motivation, mental clarity and focus," C-Link for "mood, chilling and social ease," BPC for "gut health and tissue repair," and MT2 for "getting a great tan." No dosing, no sourcing, no safety context. Just a shopping list framed as a guide.

The brevity is part of the problem. Each peptide here has a genuinely different mechanism, risk profile, and evidence base. Packaging them together as interchangeable lifestyle tools skips over a lot of important nuance, particularly for MT2, which belongs in a completely different conversation than the others.

Does the science back this up?

Partially, but the gap between what the research actually shows and what this video implies is significant. BPC-157 has the strongest preclinical case of the group. MT2 is the most legally and physiologically complex, and describing it as simply good for "a great tan" is reductive to the point of being misleading.

Starting with the sleep claim: DSIP (Delta Sleep-Inducing Peptide) was identified in 1977 by Monnier et al. in the European Journal of Biochemistry and has some evidence supporting sleep modulation in animal models. Human data is thin and inconsistent. Calling it a reliable deep sleep aid is a stretch. For the Semax-adjacent "C-Max" framing around focus and motivation, there is limited but real research on cognitive effects, including a 2014 study by Dolotov et al. in the Journal of Neurochemistry on BDNF modulation. Selank-type compounds like what appears to be "C-Link" have anxiolytic data from Russian research (Zozulya et al., 2014, Drugs in R&D), though Western replication is sparse. BPC-157 has solid animal-model data for gut and tissue healing (Sikiric et al., 2018, Current Pharmaceutical Design). Human trials are still limited. Melanotan II (MT2) does stimulate melanin production via MC1R agonism, but it also carries cardiovascular and dermatological risks that go completely unmentioned here.

What did they get wrong (or right)?

Credit where it is due: the broad functional categories are not invented. DSIP is genuinely associated with sleep research. BPC-157 does have credible preclinical evidence for gut mucosal healing and tendon repair. Calling BPC "the ultimate healing peptide" is hyperbolic, but the underlying direction is not wrong.

Where the video stumbles is MT2. Describing Melanotan II as being for "getting a great tan" treats a potent MC receptor agonist like a cosmetic product. MT2 has documented side effects including nausea, spontaneous erections, increased blood pressure, and concerns about melanocytic lesion changes (Brennan et al., 2014, British Journal of Dermatology). It is not approved for human use in the US, UK, or EU. Lumping it in with peptides that have at least some therapeutic research framing is a category error. The video also gives zero acknowledgment that nasal bioavailability for peptides varies significantly by molecule, and that formulation quality is a real variable for any compounded nasal product.

What should you actually know?

Nasal delivery of peptides is a legitimate area of research, but it is not a free pass. The nasal route bypasses first-pass metabolism, which can be useful, but it also means faster systemic absorption with less buffer if something goes wrong. For peptides like MT2, that matters considerably.

The five peptides mentioned here do not belong in the same risk bucket. DSIP and Selank-type compounds have relatively benign profiles in the literature. MT2 does not. Anyone treating this video as a starter guide should at minimum understand that "nasal spray" is not a safety category, it is a delivery method. The underlying compound determines the risk. Compounded peptides also exist outside FDA-approved drug pathways, meaning potency, purity, and sterility are not federally verified. That is not a reason to avoid them categorically, but it is a reason to work with a licensed provider who can evaluate individual health history before any of these are used.

Bottom line

This video is a surface-level overview that gets some directional things right but glosses over meaningful differences in evidence quality and safety profiles across these five peptides. The MT2 framing in particular needs to be pushed back on. A "great tan" description for a compound with cardiovascular and dermatological risk flags is not a responsible summary.